Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Califf

Showing results (431-440 of 770) with videos related to

Pageof 77
Sort By:
Journal of Thrombosis and Thrombolysis|February 11, 2012
Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparinMichael P Thomas, Kenneth W Mahaffey, Karen Chiswell, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|December 5, 2013
Framework for Curating and Applying Data Elements within Continuing Use Data: A Case Study from the Durham Diabetes CoalitionShelley A Rusincovitch, Bryan C Batch, Susan Spratt, et al.
American Heart Journal|January 25, 2008
Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromesSunil V Rao, Padma R Kaul, Lawrence Liao, et al.
Circulation|July 6, 2006
Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graftRajendra H Mehta, Emily Honeycutt, Eric D Peterson, et al.
Journal of the American College of Cardiology|June 1, 2002
Prognostic significance of elevated troponin I after percutaneous coronary interventionWarren J Cantor, L Kristin Newby, Robert H Christenson, et al.
Circulation|May 9, 2002
Differential influence of diabetes mellitus on increased jeopardized myocardium after initial angioplasty or bypass surgery: bypass angioplasty revascularization investigationKevin E Kip, Edwin L Alderman, Martial G Bourassa, et al.
Circulation|February 11, 2004
Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methodsKaren S Pieper, Anastasios A Tsiatis, Marie Davidian, et al.
Circulation|September 14, 2011
Relationship of the time interval between cardiac catheterization and elective coronary artery bypass surgery with postprocedural acute kidney injuryRajendra H Mehta, Emily Honeycutt, Uptal D Patel, et al.
Journal of the American College of Cardiology|March 19, 2004
Aspirin dose and six-month outcome after an acute coronary syndromeMartin J Quinn, Herbert D Aronow, Robert M Califf, et al.
Circulation|September 24, 2004
Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-IPadma Kaul, Paul W Armstrong, Wei-Ching Chang, et al.
Pageof 77

Showing results (431-440 of 770) with videos related to

Sort By:
Pageof 77
Journal of Thrombosis and Thrombolysis|February 11, 2012
Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparinMichael P Thomas, Kenneth W Mahaffey, Karen Chiswell, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|December 5, 2013
Framework for Curating and Applying Data Elements within Continuing Use Data: A Case Study from the Durham Diabetes CoalitionShelley A Rusincovitch, Bryan C Batch, Susan Spratt, et al.
American Heart Journal|January 25, 2008
Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromesSunil V Rao, Padma R Kaul, Lawrence Liao, et al.
Circulation|July 6, 2006
Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graftRajendra H Mehta, Emily Honeycutt, Eric D Peterson, et al.
Journal of the American College of Cardiology|June 1, 2002
Prognostic significance of elevated troponin I after percutaneous coronary interventionWarren J Cantor, L Kristin Newby, Robert H Christenson, et al.
Circulation|May 9, 2002
Differential influence of diabetes mellitus on increased jeopardized myocardium after initial angioplasty or bypass surgery: bypass angioplasty revascularization investigationKevin E Kip, Edwin L Alderman, Martial G Bourassa, et al.
Circulation|February 11, 2004
Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methodsKaren S Pieper, Anastasios A Tsiatis, Marie Davidian, et al.
Circulation|September 14, 2011
Relationship of the time interval between cardiac catheterization and elective coronary artery bypass surgery with postprocedural acute kidney injuryRajendra H Mehta, Emily Honeycutt, Uptal D Patel, et al.
Journal of the American College of Cardiology|March 19, 2004
Aspirin dose and six-month outcome after an acute coronary syndromeMartin J Quinn, Herbert D Aronow, Robert M Califf, et al.
Circulation|September 24, 2004
Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-IPadma Kaul, Paul W Armstrong, Wei-Ching Chang, et al.
Pageof 77